Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men, Part III
2007-003244-30Phase 2Active
- Sponsor
- Rijnstate
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of diazoxide and metformin in obesity and hyperinsulinemia (2 arms), sponsored by Rijnstate. Primary endpoint: Body weight. Started Jun 2007; status: active.
02
Drugs
diazoxidemetformin
03
Conditions
obesityhyperinsulinemia
Beyond the preview
Go deeper on 2007-003244-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003244-30.